Premature aging and premature age-related comorbidities in HIV-infected patients: Facts and hypotheses

Clinical Infectious Diseases

Volumn 53, Issue 11, 2011, Pages 1127-1129

  Capeau, Jacqueline ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; LAMIN A; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; THYMIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANTIVIRAL THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; COGNITIVE DEFECT; COMORBIDITY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EXPOSURE; ENVIRONMENTAL FACTOR; ETHNICITY; FOLLOW UP; FRACTURE; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNE SYSTEM; IN VITRO STUDY; INFLAMMATION; INTRAABDOMINAL FAT; KIDNEY FAILURE; LIPOATROPHY; LIPODYSTROPHY; MACROPHAGE; METABOLISM; MORTALITY; MUSCLE ATROPHY; NEOPLASM; NOTE; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOLOGY; PATIENT CARE; POLYPATHOLOGY; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SENESCENCE; SEPSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VIRUS REPLICATION;

FEMALE; HIV INFECTIONS; HUMANS; MALE;

EID: 80755172498     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir628     Document Type: Note

References (23)

1. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009;338:a3172.
2. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis, 2008;47:542-53.
3. Hasse B, Ledergerber B, Egger M, et al. Aging and non-HIV-associated co-morbidity in HIV1 persons: the SHCS. 18th Conference on Retroviruses and Opportunistic Infection. Boston, MA, USA, CROI 2011.
4. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005"surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008;48:590-8.
5. Guaraldi G, Orlando G, Zona S, et al. Premature age-related co-morbidities among HIV-infected persons compared to the general population. Clin Infect Dis 2011;doi: 10.1093/cid/cir627.
6. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010;16:238-46.
7. Worman HJ, Fong LG, Muchir A, Young SG. Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 2009;119:1825-36.
8. Ragnauth CD, Warren DT, Liu Y, et al. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010;121: 2200-10.
9. Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J. HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med 2010;16:218-29.
10. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011;121:2126-32.
11. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008;214:231-41. (Pubitemid 351160160)
12. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation and senescence predict subclinical carotid artery disease in HIVinfected women. J Infect Dis 2011;203: 452-63.
13. Lyons JL, Uno H, Ancuta P, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 2011;57:371-9.
14. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011;203:780-90.
15. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5:e203.
16. Tien PC, Choi AI, Zolopa AR, et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010;55: 316-22.
17. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010;201:1788-95.
18. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009;17:118-23.
19. Lagathu C, Eustace B, Prot M, et al. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther 2007;12:489-500. (Pubitemid 47041147)
20. Lefèvre C, Auclair M, Boccara F, et al. Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol 2010;30:2611-20.
21. Samaras K, Gan SK, Peake PW, Carr A, Campbell LV. Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection. Obesity 2009;17:53-9. (Pubitemid 50331903)
22. Guaraldi G, Stentarelli C, Zona S, et al. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 2010;208:222-7.
23. Scherzer R, Heymsfield SB, Lee D, et al. Decreased limb muscle and increased central adiposity are associated with 5-year allcause mortality in HIV infection. AIDS 2011;25:1405-14.